The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.
Condition | Intervention | Phase |
---|---|---|
Onychomycosis of Toenails | Drug: AN2690 Topical Solution, 5% Drug: Solution Vehicle |
Phase 3 |
Study Type: | Interventional |
Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
Official Title: | A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of AN2690 Topical Solution, 5%, vs. Solution Vehicle in the Treatment of Onychomycosis of the Toenail in Adults |
Date of article/Start date of trial: 21 February 2011
Trial Phase: Phase 3
clinical Trials Gov ID: NCT01302119
Trial status: Completed